| Quarter | Score |
|---|---|
| 2022-Q3 | 65.7 |
| 2022-Q4 | 49.4 |
| 2023-Q1 | 49.2 |
| 2023-Q2 | 36.1 |
| 2023-Q3 | 48.7 |
| 2023-Q4 | 36.6 |
| 2024-Q1 | 46.1 |
| 2024-Q2 | 45.6 |
| 2024-Q3 | 75.6 |
| 2024-Q4 | 74.2 |
| 2025-Q1 | 74.4 |
| 2025-Q2 | 74.0 |
| 2025-Q3 | 74.0 |
| 2025-Q4 | 58.8 |
| 2026-Q1 | 74.1 |
| 2026-Q2 | 76.7 |
Solid consensus with smart money net adding at reasonable prices
Trading 34.7% below funds' estimated purchase price
2 of 18 tracked funds hold OCSL. Avg conviction: 0.7%. Net holding. First tracked at $17.98 (current -34.7% vs tracked).
Oaktree Capital has 1.3% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 1.3% | Add |
| Citadel Advisors | 0.0% | Reduce |